ProShare Advisors LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,763 shares of the company’s stock after selling 5,820 shares during the period. ProShare Advisors LLC’s holdings in Intuitive Surgical were worth $7,801,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Checchi Capital Advisers LLC boosted its position in shares of Intuitive Surgical by 4.5% in the second quarter. Checchi Capital Advisers LLC now owns 392 shares of the company’s stock worth $259,000 after buying an additional 17 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its position in shares of Intuitive Surgical by 6.3% in the second quarter. Robeco Institutional Asset Management B.V. now owns 35,258 shares of the company’s stock worth $23,320,000 after buying an additional 2,078 shares in the last quarter. New York State Teachers Retirement System boosted its position in shares of Intuitive Surgical by 0.7% in the second quarter. New York State Teachers Retirement System now owns 64,484 shares of the company’s stock worth $42,650,000 after buying an additional 464 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in shares of Intuitive Surgical by 591.8% in the second quarter. Daiwa Securities Group Inc. now owns 5,880 shares of the company’s stock worth $3,889,000 after buying an additional 5,030 shares in the last quarter. Finally, Shell Asset Management Co. boosted its position in shares of Intuitive Surgical by 138.4% in the second quarter. Shell Asset Management Co. now owns 7,487 shares of the company’s stock worth $4,952,000 after buying an additional 4,347 shares in the last quarter. 90.53% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical, Inc. (NASDAQ:ISRG) traded up 1.24% on Wednesday, hitting $670.42. 283,363 shares of the stock traded hands. The stock has a 50 day moving average of $637.73 and a 200 day moving average of $672.81. Intuitive Surgical, Inc. has a 52 week low of $502.01 and a 52 week high of $727.25. The firm has a market capitalization of $25.98 billion, a PE ratio of 36.16 and a beta of 0.52.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 18th. The company reported $6.19 EPS for the quarter, topping analysts’ consensus estimates of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to analysts’ expectations of $650.49 million. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The business’s quarterly revenue was up 15.8% on a year-over-year basis. During the same period last year, the company posted $5.24 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post $22.19 earnings per share for the current year.
A number of equities analysts have recently weighed in on ISRG shares. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $753.00 price target on the stock in a research report on Wednesday, September 14th. Wells Fargo & Company started coverage on shares of Intuitive Surgical in a research report on Thursday, October 13th. They set an “outperform” rating on the stock. BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday, September 20th. J P Morgan Chase & Co reissued a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, September 20th. Finally, Canaccord Genuity lifted their price target on shares of Intuitive Surgical from $750.00 to $800.00 and gave the stock a “buy” rating in a research report on Wednesday, October 19th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $729.16.
In other Intuitive Surgical news, Director Lonnie M. Smith sold 275 shares of the firm’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $646.50, for a total value of $177,787.50. Following the completion of the sale, the director now directly owns 235,890 shares in the company, valued at $152,502,885. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary S. Guthart sold 13,515 shares of the firm’s stock in a transaction on Monday, November 7th. The stock was sold at an average price of $680.68, for a total transaction of $9,199,390.20. Following the completion of the sale, the chief executive officer now owns 82,880 shares of the company’s stock, valued at $56,414,758.40. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
What are top analysts saying about Intuitive Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intuitive Surgical Inc. and related companies.